Screener
Aquestive Therapeutics, Inc. AQST Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $98.49M+62.7% | $110.73M+61.3% | $121.17M+69.4% | $129.06M+65.7% | $60.54M-32.6% | ||
| $7.37M-9.3% | $8.07M+12.1% | $6.17M+2.1% | $7.88M+12.3% | $8.13M+16.6% | ||
| $118.49M+45.0% | $130.18M+46.0% | $149.27M+69.2% | $151.67M+57.1% | $81.72M-21.4% | ||
| $3.96M+2.6% | $3.84M+1.0% | $3.89M+2.5% | $3.92M+1.8% | $3.86M-1.6% | ||
| $132.1M+41.0% | $141.13M+38.0% | $160.43M+58.2% | $163.56M+48.7% | $93.7M-20.3% | ||
| $8.97M-25.0% | $11.89M-3.2% | $29.86M+190% | $10.87M+43.5% | $11.95M+110% | ||
| $1.09M0.0% | $1.09M+4.2% | $1.09M+4.2% | $1.09M+4.2% | $1.09M+4.4% | ||
| $32K-99.7% | $14.54M+52.4% | $9.99M— | $9.54M— | $9.54M— | ||
| $16.48M-28.8% | $31.75M+73.5% | $47.61M+152% | $25.57M+68.8% | $23.16M+66.6% | ||
| $55M+22.2% | $45M0.0% | $45M0.0% | $45M0.0% | $45M0.0% | ||
| $188.69M+13.5% | $175.18M+7.4% | $194.09M+20.1% | $167.67M+7.9% | $166.29M+8.6% | ||
| 250M0.0% | 250M0.0% | 250M0.0% | 250M0.0% | 250M0.0% | ||
| -$477.92M-19.6% | -$455.06M-17.8% | -$447M-23.1% | -$415.14M-19.9% | -$399.69M-19.4% | ||
| -$56.59M+22.0% | -$34.05M+44.1% | -$33.66M+44.0% | -$4.11M+91.0% | -$72.59M-105% | ||
| $132.1M+41.0% | $141.13M+38.0% | $160.43M+58.2% | $163.56M+48.7% | $93.7M-20.3% |
FAQ
- What are Aquestive Therapeutics, Inc.'s total assets?
- Aquestive Therapeutics, Inc. (AQST) holds $132.1M in total assets, up 41.0% year over year.
- How much debt does Aquestive Therapeutics, Inc. have?
- Aquestive Therapeutics, Inc. carries $63.4M in total debt against -$56.6M of shareholders' equity, a debt-to-equity ratio of -1.12.
- How much cash does Aquestive Therapeutics, Inc. have?
- Aquestive Therapeutics, Inc. holds $98.5M in cash and equivalents.
- Can Aquestive Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 7.19 — current assets exceed current liabilities.
- Where does Aquestive Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Aquestive Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
